Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2011 (Vol. 31, No. 18)

International Aging Research Portfolio (IARP)

  • Nice design, many ways to explore site
  • Nothing significant

I never grow tired of exploring fantastically designed websites, and with the International Aging Research Portfolio I was not disappointed. The IARP is an independent nonprofit initiative that brings together resources for the many parties involved in aging research including charities, academic and corporate researchers, and patient advocacy groups. Besides simply having a beautifully manicured website, the IARP provides a large amount of information related to the funding of aging research. This information is perhaps most easily browsed via the “Search Projects” field on the homepage, wherein 102 (yes, that’s right!) different topics are indexed to allow users to literally search anything from A–Z (or rather, from “accumulative-waste theory” to “zinc metabolism”). Alternatively, visitors to the site can explore sections such as funding organizations and sources, commercial applications and companies, and biotechnology video casts and training. No matter how you decide to browse the site, you will find plenty of useful information.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »